Proniras

Seattle, WA · Founded 2017 · Privately Held (backing)

Operator of a clinical-stage biotechnology company intended for the development of novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system (CNS)… Proniras is based in Seattle, WA and was founded in 2017. It was valued at $17.5 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $11.2 million across 2 recorded rounds; the latest was a $6.9 million early-stage round in Dec 2023.

PMV mark · valuation
$17.5M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$11.2M
Last round
Early Stage VC
Dec 2023
Cap table — not yet on record

Proniras's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Proniras with a free account
  • ·Watch Proniras: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Proniras

Where does Proniras's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Proniras's 2 recorded funding rounds.